Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

venBio

venBio
VC INVESTOR TYPE
Active STATUS
6 PROFESSIONALS
43 INVESTMENTS
20 PORTFOLIO
19 EXITS
Description

venBio is a venture capital firm that invests in the life science sector from early to late stages. It prefers to invest in firms operating in the healthcare, therapeutics and life science sector. The firm is based in San Francisco, California and was founded in 2009.

Website
Investor Status
Actively Seeking New Investments
Year Founded
2009
Primary Investor Type
Venture Capital
Primary Office
  • 1700 Owens Street
  • Suite 595
  • San Francisco, CA 94158
  • United States

+1 (415) 000-0000

venBio Investments (43)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NorthSea Therapeutics 08-Jan-2020 Early Stage VC 0000 Biotechnology Generating Revenue 0000000 000000 00
0000000 08-Oct-2019 00000 00000 0000 Therapeutic Devices Generating Revenue 00000 0000000 00
0000000 0000000000 03-Oct-2019 00000 00000 0000 Biotechnology Pre-Clinical Trials 0000000 000000 00
000000000 10-Sep-2019 00000 00000 0000 Drug Discovery Startup 0000000 000000 00
0000000 0000000000 10-Apr-2019 00000 00000 0000 Drug Discovery Generating Revenue 0000000 000000 00
00000 000000000000 12-Dec-2018 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 00000 0000000 00
000000000 00000000 12-Dec-2018 00000 00000 0000 Other Pharmaceuticals and Biotechnology Generating Revenue 00000 0000000 00.0
00000 00000000000 06-Dec-2018 00000 00000 000.00 Therapeutic Devices Clinical Trials - Phase 3 00000 0000000 00
Turning Point Therapeutics 19-Oct-2018 Mezzanine 0000 Biotechnology Clinical Trials - General 000000 0000000 00
Neurogastrx 01-Aug-2018 Early Stage VC 0000 Pharmaceuticals Generating Revenue 00000 0000000 00
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore venBio’s full profile, request a free trial.

venBio Exits (18)

Company Name Exit Date Exit Type Exit Size Status Buyers
Akero Therapeutics 20-Jun-2019 IPO 0000 Completed
0000000 00000 0000 17-Apr-2019 000 00000 Completed
000000000 00000000 28-Mar-2019 000 00000 Completed
0000000 06-Mar-2019 000000 0000000000 00000 Completed
0000000 19-Apr-2018 000000 0000000000 00000 Completed
00000 000000000000 25-Jan-2018 000 00000 Completed
  • 2 buyers
0000000 09-Nov-2017 000 00000 Completed
0000000 0000000000 17-Mar-2017 000000 0000000000 00000 Completed
Oncobiologics 13-May-2016 IPO 0000 Completed
Corvus Pharmaceuticals 23-Mar-2016 IPO 000.00 Completed
To view this investor’s complete exits history, request access »

venBio Team (12)

Name Title Deals Funds Boards Office Contact
Info
Robert Adelman MD Managing Partner & Co-Founder 00 0 0 San Francisco, CA
Corey Goodman Ph.D Managing Partner 0 0 0 San Francisco, CA
Aaron Royston MD Partner 0 0 0 San Francisco, CA
Richard Gaster MD Principal 0 0 0 San Francisco, CA
Yvonne Yamanaka Ph.D Vice President 0 New York, NY

5 Former Team Members

You’re viewing 5 of 12 team members. Get the full list »